AbbVie Inc (ABBV) stock news · P/E 81, rev $16.99B
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
This ABBV news page leads with what AbbVie Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABBV yet. We will not pad this page with generic market recap.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABBV stock page; for the tape open the quote page.
Not investment advice.